Aptabio ranked among the top searched stocks on 3 days within the past month.


As of 9:30 AM on the 5th, Aptabio is trading at 71,200 KRW, up 7.88% from the previous day. This marks an 89.87% increase compared to December 11.

Over the past 5 days, individual investors have net sold 151,736 shares, while foreigners and institutions have net bought 99,088 shares and 63,819 shares, respectively.


On January 4, Aptabio was a market topic for hitting the upper price limit following its application for Phase 2 clinical trials of a COVID-19 treatment in the U.S.



※Source: AI Investment Assistant AI Rasero


※ This article was generated in real-time by an automatic article creation algorithm jointly developed by Asia Economy and financial AI specialist Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing